Skip to main content

In this Issue

  • Upper respiratory, cold, allergy and sinus category sees ‘impressive’ growth

    The upper respiratory, cold-allergy-sinus liquids and tablets segments combined saw a 4% growth in sales across multi-outlets for the last 12 months compared with the previous year, with growth in drug and food channels for both UR segments. Impressive growth of 7% from cold-allergy-sinus liquids in the drug channel was driven by manufacturer Reckitt Benckiser with 16% growth year over year (Figure 1).

  • Hy-Vee ties new diabetes lifestyle management program to on-site dietitians

    WEST DES MOINES, Iowa — Hy-Vee on Friday announced it now offers a Begin for Diabetes lifestyle management program, in addition to its existing Begin and Begin 4 Kids programs. All three options are led by registered dietitians in Hy-Vee’s 244 stores across its eight-state region.

  • At 75, Lewis more relevant than ever

    I never understood people who root against the hometown team. I once knew a New York Yankees fan that was pulling for the Boston Red Sox in the 1986 World Series. (Are you kidding me — the FLIPPING Red Sox?!) I bet him $50 just on principal; what kind of demented Yankees fan could ever root for the Red Sox to beat another New York team? Surely, this is the kind of sick lunatic that the Department of Homeland Security, the FBI, the CIA and just about every federal and local law enforcement agency in the country should have on a watch list.

  • Lewis hones broad product strategy

    How does Lewis Drug thrive in a crowded and super-competitive marketplace? The company’s success formula is no big secret, said Bob Meyer, SVP of merchandise and marketing, but that doesn’t mean it’s easy to replicate. “[We try] to find niches in the marketplace where we feel we can do better than our competition,” Meyer explained.

  • Innovations aid expansion of services

    As Lewis Drug marks its 75th year in business, its long-term success “still comes down to relationships,” according to Bill Ladwig, SVP of professional services.

  • Future Trends: Integration, chronic care lie ahead for pharmacy

    What will retail pharmacy look like in 2027? Predicting the future is always iffy, but it’s certain that it will involve a lot of “C” words. Among them are connectivity; computing or, more accurately, the use of supercomputers in advanced diagnosis, medication therapy and drug development; collaboration; clinical care; and cost-saving imperatives.

  • CVS Health, Cigna unveil Cigna Health Works collaboration

    BLOOMFIELD, Conn. and WOONSOCKET, R.I. — CVS Health and Cigna on Thursday announced a new collaboration aimed at revamping the experience of patients on Cigna employer-sponsored health plans. Cigna Health Works will align Cigna-administered health benefits with CVS Pharmacy and MinuteClinic services to create a personalized health-and-wellness program for Cigna-covered patients in select markets, the companies said.

  • FDA looks to foster generics competition

    In an effort to bring down the price of prescription drugs, the Food and Drug Administration’s new commissioner, Dr. Scott Gottlieb, has made increasing competition among generics manufacturers one of his top priorities. Gottlieb unveiled the Drug Competition action plan in late June. Ahead of a July 18 public meeting, the agency released a list of branded drugs that currently have no listed patents or exclusivities, and also have no generics.

X
This ad will auto-close in 10 seconds